Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06662422 · ClinicalTrials.gov registry record · NA
Auricular Neuromodulation for FESS
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06662422 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 20 participants.
The verdict
NCT06662422, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
In this blinded prospective randomized control trial the researchers will investigate the impact of cutaneous vagal nerve stimulation on surgical conditions in patients undergoing functional and ascorbic sinus surgery (FESS). The device is an externally placed vagal nerve stimulator. The device will be applied to participants after consent and induction of anesthesia. The study team will open the randomization envelope and if the participant is assigned to stimulation the device will be turned on. In the case that the participant is assigned to the control arm, the device will be set to sham. The device will remain on for 30 minutes and removed before entering the OR. Device will be reinserted in the recovery room for another 30 minutes.
Interventions
- DEVICE Spark Biomedical Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN) System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-10-23 |
| Est. Completion | 2025-06-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06662422
The ClinicalTrials.gov registry entry for NCT06662422 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spark Biomedical Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN) System is the first listed.
NCT06662422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06662422 about?
NCT06662422 is a clinical study titled "Auricular Neuromodulation for FESS". In this blinded prospective randomized control trial the researchers will investigate the impact of cutaneous vagal nerve stimulation on surgical conditions in patients undergoing functional and ascorbic sinus surgery (FESS). The device is an externally placed vagal nerve stimulator. The device will...
What is the current status of trial NCT06662422?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-10-23. Estimated completion is 2025-06-18.
What interventions are being tested in trial NCT06662422?
The interventions under investigation include: Spark Biomedical Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN) System (DEVICE).
Who is sponsoring clinical trial NCT06662422?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.